Published On: Wed, Oct 19th, 2016

MetLife, Inc. (NYSE:MET) Analyst Review


A number of investment brokers have recently updated their price targets on shares of MetLife, Inc. (NYSE:MET).

Most recent broker ratings

10/07/2016 – MetLife, Inc. had its “buy” rating reiterated by analysts at Argus. They now have a USD 54 price target on the stock.

10/07/2016 – Credit Suisse began new coverage on MetLife, Inc. giving the company a “neutral” rating. They now have a USD 51 price target on the stock.

10/06/2016 – MetLife, Inc. had its “hold” rating reiterated by analysts at Deutsche Bank. They now have a USD 44 price target on the stock.

09/22/2016 – Wells Fargo began new coverage on MetLife, Inc. giving the company a “outperform” rating.

08/29/2016 – MetLife, Inc. had its “outperform” rating reiterated by analysts at FBR Capital Markets. They now have a USD 54 price target on the stock.

07/06/2016 – Evercore ISI began new coverage on MetLife, Inc. giving the company a “buy” rating. They now have a USD 52 price target on the stock.

06/27/2016 – MetLife, Inc. was upgraded to “buy” by analysts at Sandler O’Neill.

05/05/2016 – MetLife, Inc. had its “outperform” rating reiterated by analysts at RBC Capital. They now have a USD 62 price target on the stock.

05/05/2016 – MetLife, Inc. had its “overweight” rating reiterated by analysts at JP Morgan. They now have a USD 51 price target on the stock.

03/15/2016 – MetLife, Inc. had its “neutral” rating reiterated by analysts at UBS. They now have a USD 44 price target on the stock.

02/08/2016 – MetLife, Inc. had its “strong buy” rating reiterated by analysts at Raymond James. They now have a USD 55 price target on the stock.

02/04/2016 – MetLife, Inc. had its “overweight” rating reiterated by analysts at Barclays. They now have a USD 53 price target on the stock.

01/14/2016 – MetLife, Inc. was upgraded to “outperform” by analysts at Macquarie. They now have a USD 55 price target on the stock.

01/13/2016 – MetLife, Inc. had its “neutral” rating reiterated by analysts at Goldman Sachs. They now have a USD 46 price target on the stock.

01/05/2016 – MetLife, Inc. was downgraded to “neutral” by analysts at Citigroup. They now have a USD 51 price target on the stock.

The share price of MetLife, Inc. (NYSE:MET) was up +0.28% during the last day of trading, with a day high of 47.36. 5929218 shares were traded during the last session.

The stock’s 50 day moving average is 44.78 and its 200 day moving average is 43.27. The stock’s market capitalization is 51.43B. MetLife, Inc. has a 52-week low of 35.00 and a 52-week high of 52.45.

MetLife, Inc. (MetLife) is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America (collectively, the Americas); Asia, and Europe, the Middle East and Africa (EMEA). Its Retail segment is organized into two businesses: Life & Other, and Annuities. Its Group, Voluntary & Worksite Benefits insurance products and services include life, dental, group short- and long-term disability, property and casualty, long-term care, accidental death and dismemberment, critical illness, vision, and accident and health coverages, as well as prepaid legal plans. Its Corporate Benefit Funding segment provides funding and financing solutions that help institutional customers manage liabilities primarily associated with their qualified, nonqualified and welfare employee benefit programs using a spectrum of life and annuity-based insurance and investment products.